Invited Editorials:
67. Fitzgerald DB and Lee YCG. Pleural Infection: To drain or not to drain? Respirology 2017; in press.
66. Creaney J and Lee YCG. Diagnoses (not Diagnosis) of a pleural effusion – time to think concurrent etiologies. Ann Am Thorac Soc 2016; 13:1003-4.
65. Porcel JM, Stathopoulos G and Lee YCG. Advances and controversies in pleural diseases. J Thorac Dis 2015; 7:961-3. [PDF]
64. Lee YCG. Surgical resection of malignant pleural mesothelioma: an evidence-free practice. [Commentary]. Lancet 2014;384(9948):1080-1. [PDF]
63. Brims FJ, Lee YCG and Creaney J. The continual search for ideal biomarkers for mesothelioma: the hurdles. [Editorial]. J Thorac Dis 2013; 5:364-366. [PDF]
62. Lee YCG and Waterer GW. The need for translational research in respiratory medicine. [Editorial] Trans Resp Med 2013; 1:9. [PDF]
61. Lee YCG. Respirology: a thank you note from the outgoing editor. [Editorial] Respirology 2011; 16:1017. [PDF]
60. Lee YCG and Fysh ET. Indwelling pleural catheters: Changing the paradigm of malignant effusion management. [Editorial] J Thorac Oncol 2011; 6: 655-657. [PDF]
59. Lee YCG. Respirology: To unpathed waters and undreamed shores. [Editorial] Respirology 2009; 14: 622. [PDF]
58. Lee YCG and Wilkosz S. Malignant pleural effusions: Fixing the leaky faucet. [Editorial] Am J Respir Crit Care Med 2008; 178: 3-5. [PDF]
57. Davies HE, Lee YCG and Davies RJO. Pleurodesis for malignant pleural effusion: talc, toxicity and what next? [Editorial] Thorax 2008; 63: 572-574. [PDF]
56. Lee YCG. Hunting for a pleural fluid test for mesothelioma: Is soluble mesothelin the answer? [Editorial] Thorax 2007; 62:561-562. [PDF]
55. Lee YCG. Ongoing search for effective intrapleural therapy for empyema: Is streptokinase the answer? [Editorial] Am J Respir Crit Care Med 2004; 170: 1-2. [PDF]
54. Lee YCG and Light RW. How does pleurodesis affect lung function? [Editorial] J Respir Dis 2001; 22: 706.
Invited Reviews and Clinical Guidelines:
53. Bintcliffe OJ, Hallifax RJ, Edey A, Fellor-Kopman D, Lee YCG, Marquette CH, Tschopp JM, West D, Rahman NM and Maskell NA. Spontaneous pneumothorax – Time to rethink management? Lancet Respir Med 2015; 3:578-88. [PDF]
52. Thomas R, Jenkins S, Eastwood PR, Lee YCG and Singh B. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med 2015; 21: 338-345.
51. Piccolo F, Popowicz N, Wong D, and Lee YCG. Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy for Pleural Infection. J Thorac Dis 2015; 7:999-1008. [PDF]
50. Azzopardi M, Porcel JM, Koegelenberg CFN, Lee YCG and Fysh ET. Currrent controversies in the management of malignant pleural effusions. Semin Respir Crit Care Med 2014; 35:723-31.
49. Robinson C, Solin J, Lee YCG, Lake RA, Lesterhuis WJ. Mouse models of mesothelioma: strengths, limitations and clinical translation. Lung Cancer Manag 2014; 3: 397-410.
48. Thomas R, Francis R, Davies HEand Lee YCG. Interventional therapies for malignant pleural effusions: the present and future. Respirology 2014; 19:809-822. [PDF]
47. Yap KH, Phillips MJ and Lee YCG. Medical thoracoscopy: rigid thoracoscopy or flexi-rigid pleuroscopy? Curr Opin Pulm Med 2014; 20:358-65. [PDF]
46. Davies HE and Lee YCG. Management of malignant pleural effusions: questions that need answers. Curr Opin Pulm Med 2013; 19:374-379. [PDF]
45. Boshuizen R, Thomas R and Lee YCG. Advantages of indwelling pleural catheters for management of malignant pleural effusions. Curr Respir Care Rep 2013; 2:93-99. [PDF]
44. Thomas R and Lee YCG. Causes and management of common benign pleural effusions. Thorac Surg Clin 2013; 23:25-42. [PDF]
43. Eastwood PR, Naughton M, Calvery P, Zeng G, Beasley R, Robinson BW and Lee YCG. How to write research papers and grants: 2011 Asian Pacific Society of Respirology Annual Scientific Meeting Postgraduate Session. Respirology 2012; 17:792-801. [PDF]
42. Tobin C and Lee YCG. Pleural infection – what we need to know but don’t. Curr Opin Pulm Med 2012; 18:321-325. [PDF]
41. Rosenstengel A and Lee YCG. Pleural infection – current diagnosis and management. J Thorac Dis 2012; 4:186-193. [PDF]
40. Tobin C, Porcel JM, Wrightson JM, Waterer GW, Light RW and Lee YCG. Diagnosis of pleural infection: State-of-the-Art. Curr Respir Care Rep 2012; 1:101-110. [PDF]
39. Davies HE, Rosenstengel A and Lee YCG. The diminishing role of surgery in pleural diseases. Curr Opin Pulm Med 2011; 17: 247-254. [PDF]
38. Sriram KB, Relan V, Clarke BE, Duhig EE, Yang IA, Bowman R, Lee YCG and Fong K. Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncol 2011; 7: 737-52. [PDF]
37. Lisboa T, Waterer GW and Lee YCG. Pleural infection: Changing bacteriology and its implications. Respirology 2011; 16: 598-603. [PDF]
36. Tung A, Porcel JM, Bilaceroglu S, Creaney J and Lee YCG. Biomarkers in pleural diseases. US Respiratory Diseases 2011; 7: 26-31. [PDF]
35. Fysh ET, Smith NA and Lee YCG. Optimal chest drain size: the rise of the small-bore pleural catheter. Semin Respir Crit Care Med 2010; 31: 760-768.
34. Davies HE, Steer H, Fysh E and Lee YCG. Diagnosis and management of malignant pleural effusions. Minerva Pneumologica 2010; 49: 237-52.
33. Hooper CE, Lee YCG and Maskell NA. Setting up a specialist pleural disease service. Respirology 2010; 15:1028-1036. [PDF]
32. Lee YCG. The undiagnosed pleural effusion. UpToDate (www.uptodate.com); 2010 version.
31. Hooper C, Lee YCG and Maskell NA on behalf of the British Thoracic Society Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guidelines 2010. Thorax 2010; 65: ii4-ii17. [PDF]
30. Maskell NA on behalf of the British Thoracic Society Pleural Guideline Group. British Thoracic Society Pleural Disease Guidelines – 2010 update. Thorax 2010; 65: 667-669. [PDF]
29. Brims FJ, Lansley SM, Waterer GW and Lee YCG. Empyema Thoracic – new insights into an old disease. Eur Respir Rev 2010; 19: 220-228. [PDF]
28. Wrightson JM, Fysh E, Maskell NA and Lee YCG. Risk Reduction in Pleural Procedures: Sonography, Simulation and Supervision. Curr Opin Pulm Med 2010; 16: 340-350. [PDF]
27. Brims FJ, Davies HE and Lee YCG. Respiratory chest pain: diagnosis and management. Med Clinic N Am 2010; 94:217-232. [PDF]
26. Heffner JE, Holgate ST, Chung KF, Niederman MS, Daley CL, Jett JR, Wells AU, Tapson VF, Stradling JR, Light RW, Hansell DM, Pronovost PJ and Lee YCG. The road ahead to respiratory health – experts chart future research directions. Respirology 2009; 14: 625-636. [PDF]
25. Hooper C, Lee YCG and Maskell NA. Interferon Gamma Release Assays (IGRAs) for the diagnosis of TB pleural effusions: Hype or real hope? Curr Opin Pulm Med 2009; 15: 358-365. [PDF]
24. Davies HE, Lee YCG and Davies RJO. Authors reply:Pleurodesis by talc poudrage under simple medical thoracoscopy in malignant pleural effusion. An international opinion. [Letter] Thorax 2009; 64: 274. [PDF]
23. Davies HE, Musk AW and Lee YCG. Prophylactic radiotherapy to pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med 2008; 14: 326-330.
22. Lee YCG. Pleural fluid pH: the acid test. Intl Pleural Newsl 2008; 6: 16-17.
21. Lee YCG and Sahn SA. The undiagnosed pleural effusion. UpToDate; 2008: version 16.1 (www.uptodate.com). Last update Feb 7, 2008.
20. Davies HE and Lee YCG. Indwelling tunnelled pleural catheters. Plevra Bülteni 2008; 1: 8-13. [Turkish] www.toraks.org.tr.
19. Scherpereel A and Lee YCG. Biomarkers for mesothelioma. Curr Opin Pulm Med 2007; 13:339-343.
18. Hague J and Lee YCG. Mesothelioma. Student BMJ 2007; 15: 341.
17. Beasley R and Lee YCG. Respirology Year-In-Review 2006: Clinical Science. Respirology 2007; 12: 6-15.
16. West SD and Lee YCG. Current management of malignant pleural mesothelioma. Clin Chest Med 2006; 27: 335-354.
15. Mutsaers SE, Kalomenidis I, Wilson NA and Lee YCG. Growth factors in pleural fibrosis. Curr Opin Pulm Med 2006; 12:251-258.
14. Lee YCG and Beasley R. Respirology Year-In-Review 2005: Clinical Science. Respirology 2006; 11: 124-130.
13. Lee YCG. Pleural disease: A forgotten frontier in respiratory research. [Editorial] Respirology 2006; 11: 4-5.
12. Dalbeth N and Lee YCG. Lymphocytes in pleural effusions. Curr Opin Pulm Med 2005; 11: 334-339.
11. Kalomenidis I, Light RW and Lee YCG. Transforming Growth Factor-beta: A potential new agent for pleurodesis. Drug Design Reviews - Online 2005; 2: 47-51.
10. Lee YCG. SV40 as a causative agent in mesothelioma – a new twist to the story. Thorax 2005; 60:16.
9. Lee YCG and Light RW. Management of malignant pleural effusions. Respirology 2004; 9: 148-156.
8. West SD, Davies RJO and Lee YCG. Pleurodeses for malignant pleural effusions: current controversies and variations in practices. Curr Opin Pulm Med 2004; 10: 305-310.
7. Lee YCG and Davies RJO. Management of pleural effusions in acute medical settings: A practical guide. CPD Journal of Acute Medicine 2004; 3: 26-32.
6. Lee YCG and Light RW. Adenosine deaminase for lymphocytic pleural effusions. Intl Pleural Newsl 2004; 2: 5-6.
5. Chapman SJ, Cookson WO, Musk AW and Lee YCG. Benign asbestos pleural diseases. Curr Opin Pulm Med 2003; 9: 266-271.
4. Grove CS and Lee YCG. Vascular Endothelial Growth Factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002; 8: 294-301.
3. Lee YCG and Lane KB. The many faces of Transforming Growth Factor-beta in pleural diseases. Curr Opin Pulm Med 2001; 7: 173-179.
2. Lee YCG, Rodriguez RM, Lane KB and Light RW. Pleurodesis for recurrent pleural effusions in the new millennium. Recent Advances and Research Updates 2001; 2: 81-89.
1. Lee YCG, Light RW and Musk AW. Management of malignant pleural mesothelioma: A critical review. Curr Opin Pulm Med 2000; 6:267-274.